Effect of once‐weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo‐controlled, double‐blind, crossover trial

AIMS: To investigate the effects of semaglutide vs placebo on glucagon and other counterregulatory hormones during hypoglycaemia in type 2 diabetes (T2D). METHODS: In this double‐blind, placebo‐controlled, single‐centre trial, we randomized 38 men and women (treated only with metformin) 1:1 to 2 12‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Korsatko, Stefan, Jensen, Lene, Brunner, Martina, Sach‐Friedl, Stefanie, Tarp, Maja D., Holst, Anders G., Heller, Simon R., Pieber, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221089/
https://www.ncbi.nlm.nih.gov/pubmed/29893488
http://dx.doi.org/10.1111/dom.13422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221089/
https://www.ncbi.nlm.nih.gov/pubmed/29893488
http://dx.doi.org/10.1111/dom.13422

Ejemplares similares